Selective Laser Trabeculoplasty After Medical Treatment for Glaucoma or Ocular Hypertension.

ABSTRACT:

Importance

Primary selective laser trabeculoplasty (SLT) is a safe primary treatment for open-angle glaucoma (OAG) and ocular hypertension (OHT). However, there is limited evidence on its use as a secondary treatment, ie, after prior use of ocular hypotensive eye drops.

Objective

To evaluate outcomes following SLT after using hypotensive eye drops for at least 3 years.

Design, setting, and participants

This is a post hoc exploratory analysis of data from a multicenter randomized clinical trial conducted within the UK National Health Service. Participants were patients with OAG or OHT who participated in the LiGHT trial. Data were analyzed from February 2021 to December 2024.

Intervention

Participants were initially randomized to either primary SLT or primary hy

SUBMITTER: Konstantakopoulou E 

PROVIDER: S-EPMC11843460 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature